Considering REM Sleep Behavior Disorder in the Management of Parkinson’s Disease

References

• Matar E, McCarter SJ, St Louis EK, Lewis SJG. Current Concepts and Controversies in the Management of REM Sleep Behavior Disorder. Neurotherapeutics. 2021;18(1):107–123. doi:10.1007/s13311-020-00983-7
   PubMed Web of Science ®Google Scholar
• Dauvilliers Y, Schenck CH, Postuma RB, et al. REM sleep behaviour disorder. Nat Rev Dis Primers. 2018;4(1):19. doi:10.1038/s41572-018-0016-5
   PubMed Web of Science ®Google Scholar
• Iranzo A. The REM sleep circuit and how its impairment leads to REM sleep behavior disorder. Cell Tissue Res. 2018;373(1):245–266. doi:10.1007/s00441-018-2852-8
   PubMed Web of Science ®Google Scholar
• Iranzo A, Santamaria J, Tolosa E. The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev. 2009;13(6):385–401. doi:10.1016/j.smrv.2008.11.003
   PubMed Web of Science ®Google Scholar
• Haba-Rubio J, Marti-Soler H, Marques-Vidal P, et al. Prevalence and determinants of periodic limb movements in the general population: PLMS in the General Population. Ann Neurol. 2016;79(3):464–474. doi:10.1002/ana.24593
   PubMed Web of Science ®Google Scholar
• Pujol M, Pujol J, Alonso T, et al. Idiopathic REM sleep behavior disorder in the elderly Spanish community: a primary care center study with a two-stage design using video-polysomnography. Sleep Med. 2017;40:116–121. doi:10.1016/j.sleep.2017.07.021
   PubMed Web of Science ®Google Scholar
• Iranzo A, Santamaria J, Tolosa E. Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol. 2016;15(4):405–419. doi:10.1016/S1474-4422(16)00057-0
   PubMed Web of Science ®Google Scholar
• Högl B, Arnulf I, Bergmann M, et al. Rapid eye movement sleep behaviour disorder: past, present, and future. J Sleep Res. 2022;31:4. doi:10.1111/jsr.13612
   Web of Science ®Google Scholar
• Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB. Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain. 2017;140(7):1959–1976. doi:10.1093/brain/awx118
   PubMedGoogle Scholar
• Marras C, Chaudhuri KR. Nonmotor features of ParkinsonParkinson’s disease subtypes. Mov Disord. 2016;31(8):1095–1102. doi:10.1002/mds.26510
   PubMed Web of Science ®Google Scholar
• Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology. 1996;46(2):388–393. doi:10.1212/wnl.46.2.388
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197–211. doi:10.1016/s0197-4580(02
   PubMed Web of Science ®Google Scholar
• Valencia Garcia S, Brischoux F, Clément O, et al. Ventromedial medulla inhibitory neuron inactivation induces REM sleep without atonia and REM sleep behavior disorder. Nat Commun. 2018;9(1):504. doi:10.1038/s41467-017-02761-0
   PubMed Web of Science ®Google Scholar
• Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318(1):121–134. doi:10.1007/s00441-004-0956-9
   PubMed Web of Science ®Google Scholar
• Hawkes CH, Del Tredici K, Braak H. Parkinson’s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33(6):599–614. doi:10.1111/j.1365-2990.2007.00874.x
   PubMed Web of Science ®Google Scholar
• Van Den Berge N, Ulusoy A. Animal models of brain-first and body-first Parkinson’s disease. Neurobiol Dis. 2022;163:105599. doi:10.1016/j.nbd.2021.105599
   PubMed Web of Science ®Google Scholar
• Attems J, Jellinger KA. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson’s disease. Neuropathol Appl Neurobiol. 2008;34(4):466–467. doi:10.1111/j.1365-2990.2008.00937.x
   PubMed Web of Science ®Google Scholar
• Jellinger KA. Is Braak staging valid for all types of Parkinson’s disease? J Neural Transm. 2019;126(4):423–431. doi:10.1007/s00702-018-1898-9
   PubMed Web of Science ®Google Scholar
• Borghammer P, Van Den Berge N. Brain-First versus Gut-First Parkinson’s Disease: a Hypothesis. JPD. 2019;9(s2):S281–S295. doi:10.3233/JPD-191721
   Google Scholar
• Horsager J, Andersen KB, Knudsen K, et al. Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study. Brain. 2020;143(10):3077–3088. doi:10.1093/brain/awaa238
   PubMed Web of Science ®Google Scholar
• McKenna D, Peever J. Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder. Mov Disord. 2017;32(5):636–644. doi:10.1002/mds.27003
   PubMed Web of Science ®Google Scholar
• Leclair-Visonneau L, Clairembault T, Coron E, et al. REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease. Neurology. 2017;89(15):1612–1618. doi:10.1212/WNL.0000000000004496
   PubMed Web of Science ®Google Scholar
• Postuma RB, Adler CH, Dugger BN, et al. REM sleep behavior disorder and neuropathology in Parkinson’s disease: RBD in PD. Mov Disord. 2015;30(10):1413–1417. doi:10.1002/mds.26347
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Postuma RB. Body-first versus brain-first biological subtyping of Parkinson’s disease. Brain. 2020;143(10):2871–2873. doi:10.1093/brain/awaa293
   PubMedGoogle Scholar
• Borghammer P. The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline. JPD. 2021;11(2):455–474. doi:10.3233/JPD-202481
   Google Scholar
• Oltra J, Uribe C, Segura B, et al. Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairment. npj Parkinsons Dis. 2022;8(1):60. doi:10.1038/s41531-022-00326-7
   PubMed Web of Science ®Google Scholar
• Riboldi GM, Russo MJ, Pan L, Watkins K, Kang UJ. Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypes. npj Parkinsons Dis. 2022;8(1):110. doi:10.1038/s41531-022-00373-0
   PubMed Web of Science ®Google Scholar
• Fereshtehnejad SM, Romenets SR, Anang JBM, Latreille V, Gagnon JF, Postuma RB. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: a Prospective Cohort Comparison With Other Phenotypes. JAMA Neurol. 2015;72(8):863. doi:10.1001/jamaneurol.2015.0703
   PubMed Web of Science ®Google Scholar
• Fereshtehnejad SM, Postuma RB. Subtypes of Parkinson’s Disease: what Do They Tell Us About Disease Progression? Curr Neurol Neurosci Rep. 2017;17(4). doi:10.1007/s11910-017-0738-x
   PubMed Web of Science ®Google Scholar
• Zhang H, Iranzo A, Högl B, et al. Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior Disorder. Ann Neurol. 2022;91(3):404–416. doi:10.1002/ana.26298
   PubMed Web of Science ®Google Scholar
• Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 2013;14(8):744–748. doi:10.1016/j.sleep.2012.10.009
   PubMed Web of Science ®Google Scholar
• de Natale ER, Wilson H, Politis M. Predictors of RBD progression and conversion to synucleinopathies. Curr Neurol Neurosci Rep. 2022;22(2):93–104. doi:10.1007/s11910-022-01171-0
   PubMed Web of Science ®Google Scholar
• Miglis MG, Adler CH, Antelmi E, et al. Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. Lancet Neurol. 2021;20(8):671–684. doi:10.1016/S1474-4422(21)00176-9
   PubMed Web of Science ®Google Scholar
• Postuma RB, Iranzo A, Hu M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744–759. doi:10.1093/brain/awz030
   PubMed Web of Science ®Google Scholar
• Fereshtehnejad SM, Yao C, Pelletier A, Montplaisir JY, Gagnon JF, Postuma RB. Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study. Brain. 2019;142(7):2051–2067. doi:10.1093/brain/awz111
   PubMed Web of Science ®Google Scholar
• Del Din S, Yarnall AJ, Barber TR, et al. Continuous Real-World Gait Monitoring in Idiopathic REM Sleep Behavior Disorder. J Parkinsons Dis. 2020;10(1):283–299. doi:10.3233/JPD-191773
   PubMedGoogle Scholar
• Arora S, Baig F, Lo C, et al. Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD. Neurology. 2018;91(16):e1528–e1538. doi:10.1212/WNL.0000000000006366
   PubMed Web of Science ®Google Scholar
• Hanuška J, Rusz J, Bezdicek O, et al. Eye movements in idiopathic rapid eye movement sleep behaviour disorder: high antisaccade error rate reflects prefrontal cortex dysfunction. J Sleep Res. 2019;28(5):e12742. doi:10.1111/jsr.12742
   PubMed Web of Science ®Google Scholar
• Krupička R, Krýže P, Neťuková S, et al. Instrumental analysis of finger tapping reveals a novel early biomarker of parkinsonism in idiopathic rapid eye movement sleep behaviour disorder. Sleep Med. 2020;75:45–49. doi:10.1016/j.sleep.2020.07.019
   PubMed Web of Science ®Google Scholar
• Berg D, Postuma RB, Adler CH, et al. MDS research criteria for prodromal Parkinson’s disease. Mov Disord. 2015;30(12):1600–1611. doi:10.1002/mds.26431
   PubMed Web of Science ®Google Scholar
• Iranzo A, Marrero-González P, Serradell M, Gaig C, Santamaria J, Vilaseca I. Significance of hyposmia in isolated REM sleep behavior disorder. J Neurol. 2021;268(3):963–966. doi:10.1007/s00415-020-10229-3
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Miyamoto M. Odor identification predicts the transition of patients with isolated RBD: a retrospective study. Ann Clin Transl Neurol. 2022;9(8):1177–1185. doi:10.1002/acn3.51615
   PubMed Web of Science ®Google Scholar
• Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol. 2011;69(5):811–818. doi:10.1002/ana.22282
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang H, Mao W, et al. Visual dysfunction in patients with idiopathic rapid eye movement sleep behavior disorder. Neurosci Lett. 2019;709:134360. doi:10.1016/j.neulet.2019.134360
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Wei J, Mao CJ, et al. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson’s disease. Sleep Breath. 2016;20(4):1285–1292. doi:10.1007/s11325-016-1366-4
   PubMed Web of Science ®Google Scholar
• Ferini-Strambi L, Oertel W, Dauvilliers Y, et al. Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case–control study. J Neurol. 2014;261(6):1112–1118. doi:10.1007/s00415-014-7317-8
   PubMed Web of Science ®Google Scholar
• Zitser J, During EH, Chiaro G, Miglis MG. Autonomic impairment as a potential biomarker in idiopathic REM-sleep-behavior disorder. Autonomic Neurosci. 2019;220:102553. doi:10.1016/j.autneu.2019.05.005
   PubMed Web of Science ®Google Scholar
• Postuma RB, Lanfranchi PA, Blais H, Gagnon JF, Montplaisir JY. Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder. Mov Disord. 2010;25(14):2304–2310. doi:10.1002/mds.23347
   PubMed Web of Science ®Google Scholar
• Yang JH, Choi SH, Lee MH, et al. Association of heart rate variability with REM sleep without atonia in idiopathic REM sleep behavior disorder. J Clin Sleep Med. 2021;17(3):461–469. doi:10.5664/JCSM.8934
   PubMed Web of Science ®Google Scholar
• McCarter SJ, Gehrking TL, St Louis EK, et al. Autonomic dysfunction and phenoconversion in idiopathic REM sleep behavior disorder. Clin Auton Res. 2020;30(3):207–213. doi:10.1007/s10286-020-00674-5
   PubMed Web of Science ®Google Scholar
• Bauckneht M, Chincarini A, De Carli F, et al. Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: a systematic review and meta-analysis. Sleep Med Rev. 2018;41:266–274. doi:10.1016/j.smrv.2018.04.001
   PubMed Web of Science ®Google Scholar
• Iranzo A, Santamaría J, Valldeoriola F, et al. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder. Ann Neurol. 2017;82(3):419–428. doi:10.1002/ana.25026
   PubMed Web of Science ®Google Scholar
• Li Y, Kang W, Yang Q, et al. Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases. Neurology. 2017;88(16):1493–1500. doi:10.1212/WNL.0000000000003838
   PubMed Web of Science ®Google Scholar
• Chahine LM, Brumm MC, Caspell-Garcia C, et al. Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder. Ann Clin Transl Neurol. 2021;8(1):201–212. doi:10.1002/acn3.51269
   PubMed Web of Science ®Google Scholar
• Arnaldi D, Chincarini A, Hu MT, et al. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder. Brain. 2021;144(1):278–287. doi:10.1093/brain/awaa365
   PubMedGoogle Scholar
• Arnaldi D, Famà F, Girtler N, et al. Rapid eye movement sleep behavior disorder: a proof-of-concept neuroprotection study for prodromal synucleinopathies. Eur J Neurol. 2021;28(4):1210–1217. doi:10.1111/ene.14664
   PubMed Web of Science ®Google Scholar
• Dang-Vu TT, Gagnon JF, Vendette M, Soucy JP, Postuma RB, Montplaisir J. Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder. Neurology. 2012;79(24):2302–2306. doi:10.1212/WNL.0b013e318278b658
   PubMed Web of Science ®Google Scholar
• Heller J, Brcina N, Dogan I, et al. Brain imaging findings in idiopathic REM sleep behavior disorder (RBD) – a systematic review on potential biomarkers for neurodegeneration. Sleep Med Rev. 2017;34:23–33. doi:10.1016/j.smrv.2016.06.006
   PubMed Web of Science ®Google Scholar
• Campabadal A, Segura B, Junque C, Iranzo A. Structural and functional magnetic resonance imaging in isolated REM sleep behavior disorder: a systematic review of studies using neuroimaging software. Sleep Med Rev. 2021;59:101495. doi:10.1016/j.smrv.2021.101495
   PubMed Web of Science ®Google Scholar
• Ota Y, Kanel P, Bohnen N. Imaging of sleep disorders in pre-Parkinsonian syndromes. Curr Opin Neurol. 2022;35(4):443–452. doi:10.1097/WCO.0000000000001084
   PubMed Web of Science ®Google Scholar
• Shi M, Sheng L, Stewart T, Zabetian CP, Zhang J. New windows into the brain: central nervous system-derived extracellular vesicles in blood. Prog Neurobiol. 2019;175:96–106. doi:10.1016/j.pneurobio.2019.01.005
   PubMed Web of Science ®Google Scholar
• Kluge A, Bunk J, Schaeffer E, et al. Detection of neuron-derived pathological α-synuclein in blood. Brain. 2022;145(9):3058–3071. doi:10.1093/brain/awac115
   PubMed Web of Science ®Google Scholar
• Stefani A, Iranzo A, Holzknecht E, et al. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Brain. 2021;144(4):1118–1126. doi:10.1093/brain/awab005
   PubMed Web of Science ®Google Scholar
• Zitser J, Gibbons C, Miglis MG. The role of tissue biopsy as a biomarker in REM sleep behavior disorder. Sleep Med Rev. 2020;51:101283. doi:10.1016/j.smrv.2020.101283
   PubMed Web of Science ®Google Scholar
• Iranzo A, Fairfoul G, Ayudhaya ACN, et al. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study. Lancet Neurol. 2021;20(3):203–212. doi:10.1016/S1474-4422(20)30449-X
   PubMed Web of Science ®Google Scholar
• Thaler A, Bregman N, Gurevich T, et al. Parkinson’s disease phenotype is influenced by the severity of the mutations in the GBA gene. Parkinsonism Relat Disord. 2018;55:45–49. doi:10.1016/j.parkreldis.2018.05.009
   PubMed Web of Science ®Google Scholar
• Krohn L, Ruskey JA, Rudakou U, et al. GBA variants in REM sleep behavior disorder: a multicenter study. Neurology. 2020;95(8):e1008–e1016. doi:10.1212/WNL.0000000000010042
   PubMed Web of Science ®Google Scholar
• Honeycutt L, Montplaisir JY, Gagnon JF, et al. Glucocerebrosidase mutations and phenoconversion of REM sleep behavior disorder to parkinsonism and dementia. Parkinsonism Relat Disord. 2019;65:230–233. doi:10.1016/j.parkreldis.2019.04.016
   PubMed Web of Science ®Google Scholar
• Krohn L, Wu RYJ, Heilbron K, et al. Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies. Ann Neurol. 2020;87(4):584–598. doi:10.1002/ana.25687
   PubMed Web of Science ®Google Scholar
• Ye G, Li Y, Zhou L, et al. Predictors of Conversion to α-Synucleinopathy Diseases in Idiopathic Rapid Eye Movement Sleep Behavior Disorder. J Parkinsons Dis. 2020;10(4):1443–1455. doi:10.3233/JPD-202243
   PubMedGoogle Scholar
• Terzaghi M, Toscano G, Casoni F, et al. Assessment of cognitive profile as a prodromal marker of the evolution of REM sleep Behavior Disorder. Sleep. 2019. doi:10.1093/sleep/zsz103
   PubMed Web of Science ®Google Scholar
• Vendette M, Montplaisir J, Gosselin N, et al. Brain perfusion anomalies in rapid eye movement sleep behavior disorder with mild cognitive impairment. Mov Disord. 2012;27(10):1255–1261. doi:10.1002/mds.25034
   PubMed Web of Science ®Google Scholar
• Jozwiak N, Postuma RB, Montplaisir J, et al. REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson’s Disease. Sleep. 2017;40:8. doi:10.1093/sleep/zsx101
   Web of Science ®Google Scholar
• Marchand DG, Montplaisir J, Postuma RB, Rahayel S, Gagnon JF. Detecting the Cognitive Prodrome of Dementia with Lewy Bodies: a Prospective Study of REM Sleep Behavior Disorder. Sleep. 2017;40:1. doi:10.1093/sleep/zsw014
   Web of Science ®Google Scholar
• Gagnon JF, Vendette M, Postuma RB, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol. 2009;66(1):39–47. doi:10.1002/ana.21680
   PubMed Web of Science ®Google Scholar
• McCarter SJ, Tabatabai GM, Jong HY, et al. REM sleep atonia loss distinguishes synucleinopathy in older adults with cognitive impairment. Neurology. 2020;94(1):e15–e29. doi:10.1212/WNL.0000000000008694
   PubMed Web of Science ®Google Scholar
• Rahayel S, Postuma RB, Montplaisir J, et al. Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorder. Neurology. 2018;90(20):e1759–e1770. doi:10.1212/WNL.0000000000005523
   PubMed Web of Science ®Google Scholar
• Rahayel S, Postuma RB, Montplaisir J, et al. A Prodromal Brain-Clinical Pattern of Cognition in Synucleinopathies. Ann Neurol. 2021;89(2):341–357. doi:10.1002/ana.25962
   PubMed Web of Science ®Google Scholar
• Rémillard-Pelchat D, Rahayel S, Gaubert M, et al. Comprehensive Analysis of Brain Volume in REM Sleep Behavior Disorder with Mild Cognitive Impairment. J Parkinsons Dis. 2022;12(1):229–241. doi:10.3233/JPD-212691
   PubMedGoogle Scholar
• Postuma RB, Iranzo A, Hogl B, et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol. 2015;77(5):830–839. doi:10.1002/ana.24385
   PubMed Web of Science ®Google Scholar
• Génier Marchand D, Postuma RB, Escudier F, et al. How does dementia with Lewy bodies start? Prodromal cognitive changes in REM sleep behavior disorder. Ann Neurol. 2018;83(5):1016–1026. doi:10.1002/ana.25239
   PubMed Web of Science ®Google Scholar
• Génier Marchand D, Montplaisir J, Postuma RB, Rahayel S, Gagnon JF. Detecting the Cognitive Prodrome of Dementia with Lewy Bodies: a Prospective Study of REM Sleep Behavior Disorder. Sleep. 2017;40:1. doi:10.1093/sleep/zsw014
   Web of Science ®Google Scholar
• Heinzel S, Berg D, Gasser T, et al. Update of the MDS research criteria for prodromal Parkinson’s disease. Mov Disord. 2019;34(10):1464–1470. doi:10.1002/mds.27802
   PubMed Web of Science ®Google Scholar
• Gagnon JF, Bertrand JA, Génier Marchand D. Cognition in rapid eye movement sleep behavior disorder. Front Neurol. 2012;3:82. doi:10.3389/fneur.2012.00082
   PubMedGoogle Scholar
• Ferini-Strambi L, Fasiello E, Sforza M, Salsone M, Galbiati A. Neuropsychological, electrophysiological, and neuroimaging biomarkers for REM behavior disorder. Expert Rev Neurother. 2019;19(11):1069–1087. doi:10.1080/14737175.2019.1640603
   PubMed Web of Science ®Google Scholar
• Figorilli M, Lanza G, Congiu P, et al. Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): a Narrative Review. Brain Sci. 2021;11(12):1588. doi:10.3390/brainsci11121588
   PubMed Web of Science ®Google Scholar
• Valomon A, Riedner BA, Jones SG, et al. A high-density electroencephalography study reveals abnormal sleep homeostasis in patients with rapid eye movement sleep behavior disorder. Sci Rep. 2021;11(1):4758. doi:10.1038/s41598-021-83980-w
   PubMed Web of Science ®Google Scholar
• Ferri R, Rundo F, Silvani A, et al. REM Sleep EEG Instability in REM Sleep Behavior Disorder and Clonazepam Effects. Sleep. 2017;40:8. doi:10.1093/sleep/zsx080
   Web of Science ®Google Scholar
• Ferri R, Zucconi M, Marelli S, Plazzi G, Schenck CH, Ferini-Strambi L. Effects of long-term use of clonazepam on nonrapid eye movement sleep patterns in rapid eye movement sleep behavior disorder. Sleep Med. 2013;14(5):399–406. doi:10.1016/j.sleep.2013.01.007
   PubMed Web of Science ®Google Scholar
• Shin C, Park H, Lee WW, Kim HJ, Kim HJ, Jeon B. Clonazepam for probable REM sleep behavior disorder in Parkinson’s disease: a randomized placebo-controlled trial. J Neurol Sci. 2019;401:81–86. doi:10.1016/j.jns.2019.04.029
   PubMed Web of Science ®Google Scholar
• Hadi F, Agah E, Tavanbakhsh S, et al. Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson’s disease and sleep disorders: a randomized, double-blind trial. Neurol Sci. 2022;43(10):6141–6148. doi:10.1007/s10072-022-06188-4
   PubMed Web of Science ®Google Scholar
• Yan J, Liu A, Huang J, et al. Pharmacological Interventions for REM Sleep Behavior Disorder in Parkinson’s Disease: a Systematic Review. Front Aging Neurosci. 2021;13:709878. doi:10.3389/fnagi.2021.709878
   PubMed Web of Science ®Google Scholar
• Que Z, Zheng C, Zhao Z, et al. The treatment efficacy of pharmacotherapies for rapid eye movement sleep behavior disorder with polysomnography evaluation: a systematic review and meta-analysis. Heliyon. 2022;8(11):e11425. doi:10.1016/j.heliyon.2022.e11425
   PubMed Web of Science ®Google Scholar
• Brooks PL, Peever JH. Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice. J Neurosci. 2011;31(19):7111–7121. doi:10.1523/JNEUROSCI.0347-11.2011
   PubMed Web of Science ®Google Scholar
• Parrino L, Ferri R, Bruni O, Terzano MG. Cyclic alternating pattern (CAP): the marker of sleep instability. Sleep Med Rev. 2012;16(1):27–45. doi:10.1016/j.smrv.2011.02.003
   PubMed Web of Science ®Google Scholar
• Kutlu A, Işeri P, Selekler M, Benbir G, Karadeniz D. Cyclic alternating pattern analysis in REM sleep behavior disorder. Sleep and Breathing. 2013;17(1):209–215. doi:10.1007/s11325-012-0675-5
   PubMed Web of Science ®Google Scholar
• Melpignano A, Parrino L, Santamaria J, et al. Isolated rapid eye movement sleep behavior disorder and cyclic alternating pattern: is sleep microstructure a predictive parameter of neurodegeneration? Sleep. 2019;42(10):zsz142. doi:10.1093/sleep/zsz142
   PubMed Web of Science ®Google Scholar
• O’Reilly C, Godin I, Montplaisir J, Nielsen T. REM sleep behaviour disorder is associated with lower fast and higher slow sleep spindle densities. J Sleep Res. 2015;24(6):593–601. doi:10.1111/jsr.12309
   PubMed Web of Science ®Google Scholar
• Christensen JAE, Kempfner J, Zoetmulder M, et al. Decreased sleep spindle density in patients with idiopathic REM sleep behavior disorder and patients with Parkinson’s disease. Clin Neurophysiol. 2014;125(3):512–519. doi:10.1016/j.clinph.2013.08.013
   PubMed Web of Science ®Google Scholar
• Ruffini G, Ibañez D, Castellano M, et al. Deep Learning With EEG Spectrograms in Rapid Eye Movement Behavior Disorder. Front Neurol. 2019;10:806. doi:10.3389/fneur.2019.00806
   PubMed Web of Science ®Google Scholar
• Gong S-Y, Shen Y, Gu H-Y, et al. Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD. Nat Sci Sleep. 2022;14:407–418. doi:10.2147/NSS.S354063
   PubMed Web of Science ®Google Scholar
• Lanza G, DelRosso LM, Ferri R. Sleep and homeostatic control of plasticity. Handb Clin Neurol. 2022;184:53–72. doi:10.1016/B978-0-12-819410-2.00004-7
   PubMedGoogle Scholar
• Fisicaro F, Lanza G, Cantone M, et al. Clinical and Electrophysiological Hints to TMS in De Novo Patients with Parkinson’s Disease and Progressive Supranuclear Palsy. J Pers Med. 2020;10(4):E274. doi:10.3390/jpm10040274
   PubMed Web of Science ®Google Scholar
• Cantone M, Lanza G, Ranieri F, Opie GM, Terranova C. Editorial: non-invasive Brain Stimulation in the Study and Modulation of Metaplasticity in Neurological Disorders. Front Neurol. 2021;12:721906. doi:10.3389/fneur.2021.721906
   PubMed Web of Science ®Google Scholar
• Di Lazzaro V, Bella R, Benussi A, et al. Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia. Clin Neurophysiol. 2021;132(10):2568–2607. doi:10.1016/j.clinph.2021.05.035
   PubMed Web of Science ®Google Scholar
• Nardone R, Bergmann J, Kunz A, et al. Cortical afferent inhibition is reduced in patients with idiopathic REM sleep behavior disorder and cognitive impairment: a TMS study. Sleep Med. 2012;13(7):919–925. doi:10.1016/j.sleep.2012.03.009
   PubMed Web of Science ®Google Scholar
• Nardone R, Bergmann J, Brigo F, et al. Functional evaluation of central cholinergic circuits in patients with Parkinson’s disease and REM sleep behavior disorder: a TMS study. J Neural Transm. 2013;120(3):413–422. doi:10.1007/s00702-012-0888-6
   PubMed Web of Science ®Google Scholar
• Lanza G, Aricò D, Lanuzza B, et al. Facilitatory/inhibitory intracortical imbalance in REM sleep behavior disorder: early electrophysiological marker of neurodegeneration? Sleep. 2020;43(3):zsz242. doi:10.1093/sleep/zsz242
   PubMed Web of Science ®Google Scholar
• Peever J, Luppi PH, Montplaisir J. Breakdown in REM sleep circuitry underlies REM sleep behavior disorder. Trends Neurosci. 2014;37(5):279–288. doi:10.1016/j.tins.2014.02.009
   PubMed Web of Science ®Google Scholar
• Lanza G, Cosentino FII, Lanuzza B, et al. Reduced Intracortical Facilitation to TMS in Both Isolated REM Sleep Behavior Disorder (RBD) and Early Parkinson’s Disease with RBD. J Clin Med. 2022;11(9):2291. doi:10.3390/jcm11092291
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Kamble N, Yadav R, Stezin A, Pal PK. Abnormal Intracortical Functions in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder. Can J Neurol Sci. 2022;49(5):672–677. doi:10.1017/cjn.2021.206
   PubMed Web of Science ®Google Scholar
• Lanza G, Fisicaro F, Cantone M, et al. Repetitive transcranial magnetic stimulation in primary sleep disorders. Sleep Med Rev. 2023;67:101735. doi:10.1016/j.smrv.2022.101735
   PubMed Web of Science ®Google Scholar
• Magnano I, Pes GM, Cabboi MP, et al. Comparison of brainstem reflex recordings and evoked potentials with clinical and MRI data to assess brainstem dysfunction in multiple sclerosis: a short-term follow-up. Neurol Sci. 2016;37(9):1457–1465. doi:10.1007/s10072-016-2604-z
   PubMed Web of Science ®Google Scholar
• de Natale ER, Ginatempo F, Laccu I, et al. Vestibular Evoked Myogenic Potentials Are Abnormal in Idiopathic REM Sleep Behavior Disorder. Front Neurol. 2018;9:911. doi:10.3389/fneur.2018.00911
   PubMed Web of Science ®Google Scholar
• de Natale ER, Ginatempo F, Paulus KS, et al. Abnormalities of vestibular-evoked myogenic potentials in idiopathic Parkinson’s disease are associated with clinical evidence of brainstem involvement. Neurol Sci. 2015;36(6):995–1001. doi:10.1007/s10072-014-2054-4
   PubMed Web of Science ®Google Scholar
• Puligheddu M, Figorilli M, Serra A, et al. REM Sleep without atonia correlates with abnormal vestibular-evoked myogenic potentials in isolated REM sleep behavior disorder. Sleep. 2019;42(9):zsz128. doi:10.1093/sleep/zsz128
   PubMed Web of Science ®Google Scholar
• Xie WY, Shen Y, Chen Y, et al. REM sleep without atonia and vestibular-evoked myogenic potentials: clinical brainstem dysfunction in early-stage Parkinson’s disease and isolated REM sleep behavior disorder. Sleep Med. 2022;89:122–129. doi:10.1016/j.sleep.2021.12.004
   PubMed Web of Science ®Google Scholar
• Stefani A, Holzknecht E, Högl B. Clinical neurophysiology of REM parasomnias. Handb Clin Neurol. 2019;161:381–396. doi:10.1016/B978-0-444-64142-7.00062-X
   PubMedGoogle Scholar
• Perkins JE, Janzen A, Bernhard FP, et al. Saccade, Pupil, and Blink Responses in Rapid Eye Movement Sleep Behavior Disorder. Mov Disord. 2021;36(7):1720–1726. doi:10.1002/mds.28585
   PubMed Web of Science ®Google Scholar
• Weise D, Pargac C, Pelz JO, Rumpf JJ, Fricke C, Classen J. Assessing blink reflex circuits by three different afferent routes in Parkinson’s disease. Clin Neurophysiol. 2019;130(4):582–587. doi:10.1016/j.clinph.2018.12.009
   PubMed Web of Science ®Google Scholar
• Aygün D, Ertaş Fİ, Gündüz A, Benbir Şenel G, Karadeniz D, Kızıltan M. The role of pedunculopontine nucleus in isolated REM sleep behavior disorder and REM sleep without atonia. Parkinsonism Relat Disord. 2021;84:68–73. doi:10.1016/j.parkreldis.2021.01.025
   PubMed Web of Science ®Google Scholar
• Frauscher B, Nomura T, Duerr S, et al. Investigation of autonomic function in idiopathic REM sleep behavior disorder. J Neurol. 2012;259(6):1056–1061. doi:10.1007/s00415-011-6298-0
   PubMed Web of Science ®Google Scholar
• Pilotto A, Romagnolo A, Tuazon JA, et al. Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies. J Neurol Neurosurg Psychiatry. 2019;90(11):1257–1263. doi:10.1136/jnnp-2019-320846
   PubMed Web of Science ®Google Scholar
• Jung KY, Cho JH, Ko D, et al. Increased Corticomuscular Coherence in Idiopathic REM Sleep Behavior Disorder. Front Neurol. 2012;3:60. doi:10.3389/fneur.2012.00060
   PubMedGoogle Scholar
• Choi GS, Yun JY, Hwang S, et al. Can Corticomuscular Coherence Differentiate between REM Sleep Behavior Disorder with or without Parkinsonism? J Clin Med. 2021;10(23):5585. doi:10.3390/jcm10235585
   PubMed Web of Science ®Google Scholar
• Raggi A, Manconi M, Consonni M, et al. Event-related potentials in idiopathic rapid eye movements sleep behaviour disorder. Clin Neurophysiol. 2007;118(3):669–675. doi:10.1016/j.clinph.2006.11.011
   PubMed Web of Science ®Google Scholar
• Raggi A, Lanza G, Ferri RA. Review on P300 in Obsessive-Compulsive Disorder. Front Psychiatry. 2021;12:751215. doi:10.3389/fpsyt.2021.751215
   PubMedGoogle Scholar
• Raggi A, Lanza G, Ferri R. Auditory mismatch negativity in bipolar disorder: a focused review. Rev Neurosci. 2022;33(1):17–30. doi:10.1515/revneuro-2021-0010
   PubMed Web of Science ®Google Scholar
• Gaudreault PO, Gagnon JF, Montplaisir J, et al. Abnormal occipital event-related potentials in Parkinson’s disease with concomitant REM sleep behavior disorder. Parkinsonism Relat Disord. 2013;19(2):212–217. doi:10.1016/j.parkreldis.2012.10.006
   PubMed Web of Science ®Google Scholar
• Iranzo A, Santamaría J, Rye DB, et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology. 2005;65(2):247–252. doi:10.1212/01.wnl.0000168864.97813.e0
   PubMed Web of Science ®Google Scholar
• Antelmi E, Pizza F, Donadio V, et al. Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients. Ann Clin Transl Neurol. 2019;6(9):1872–1876. doi:10.1002/acn3.50833
   PubMed Web of Science ®Google Scholar
• Berg D, Borghammer P, Fereshtehnejad SM, et al. Prodromal Parkinson disease subtypes - key to understanding heterogeneity. Nat Rev Neurol. 2021;17(6):349–361. doi:10.1038/s41582-021-00486-9
   PubMed Web of Science ®Google Scholar
• Gilat M, Marshall NS, Testelmans D, Buyse B, Lewis SJG. A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials. J Neurol. 2022;269(1):125–148. doi:10.1007/s00415-020-10353-0
   PubMed Web of Science ®Google Scholar
• de Almeida CMO, Pachito DV, Sobreira-Neto MA, Tumas V, Eckeli AL. Pharmacological treatment for REM sleep behavior disorder in Parkinson disease and related conditions: a scoping review. J Neurol Sci. 2018;393:63–68. doi:10.1016/j.jns.2018.08.008
   PubMed Web of Science ®Google Scholar
• Li SX, Lam SP, Zhang J, et al. A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder. Sleep Med. 2016;21:114–120. doi:10.1016/j.sleep.2015.12.020
   PubMed Web of Science ®Google Scholar
• Ferri R, Marelli S, Ferini-Strambi L, et al. An observational clinical and video-polysomnographic study of the effects of clonazepam in REM sleep behavior disorder. Sleep Med. 2013;14(1):24–29. doi:10.1016/j.sleep.2012.09.009
   PubMed Web of Science ®Google Scholar
• McCarter SJ, Boswell CL, St Louis EK, et al. Treatment outcomes in REM sleep behavior disorder. Sleep Med. 2013;14(3):237–242. doi:10.1016/j.sleep.2012.09.018
   PubMed Web of Science ®Google Scholar
• Kunz D, Bes F. Melatonin as a therapy in rem sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on rem-sleep regulation. Mov Disorders. 1999;14(3):507–511. doi:10.1002/1531-8257(199905)14:3<507::
   PubMed Web of Science ®Google Scholar
• Boeve B. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4(4):281–284. doi:10.1016/S1389-9457(03)00072-8
   PubMed Web of Science ®Google Scholar
• Taximaimaiti R, Luo X, Wang XP. Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson’s Disease. Curr Neuropharmacol. 2021;19(12):2233–2249. doi:10.2174/1570159X19666210517115706
   PubMed Web of Science ®Google Scholar
• Gilat M, Coeytaux jackson A, Marshall NS, et al. Melatonin for Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s disease: a Randomised Controlled Trial. Mov Disorders. 2020;35(2):344–349. doi:10.1002/mds.27886
   PubMed Web of Science ®Google Scholar
• Kashihara K, Nomura T, Maeda T, et al. Beneficial Effects of Ramelteon on Rapid Eye Movement Sleep Behavior Disorder Associated with Parkinson’s Disease - Results of a Multicenter Open Trial. Intern Med. 2016;55(3):231–236. doi:10.2169/internalmedicine.55.5464
   PubMed Web of Science ®Google Scholar
• Nomura T, Kawase S, Watanabe Y, Nakashima K. Use of ramelteon for the treatment of secondary REM sleep behavior disorder. Intern Med. 2013;52(18):2123–2126. doi:10.2169/internalmedicine.52.9179
   PubMed Web of Science ®Google Scholar
• Dusek P, Busková J, Růzicka E, et al. Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease. Clin Neuropharmacol. 2010;33(4):186–190. doi:10.1097/WNF.0b013e3181e71166
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang Y, Wu H, Lan D, Chen Y, Zhao Z. Effects of Rotigotine on REM Sleep Behavior Disorder in Parkinson Disease. J Clin Sleep Med. 2016;12(10):1403–1409. doi:10.5664/jcsm.6200
   PubMed Web of Science ®Google Scholar
• Wilson SM, Wurst MG, Whatley MF, Daniels RN. Classics in Chemical Neuroscience: pramipexole. ACS Chem Neurosci. 2020;11(17):2506–2512. doi:10.1021/acschemneuro.0c00332
   PubMed Web of Science ®Google Scholar
• Schmidt MH, Koshal VB, Schmidt HS. Use of pramipexole in REM sleep behavior disorder: results from a case series. Sleep Med. 2006;7(5):418–423. doi:10.1016/j.sleep.2006.03.018
   PubMed Web of Science ®Google Scholar
• Kumru H, Iranzo A, Carrasco E, et al. Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease. Sleep. 2008;31(10):1418–1421.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Kies B, Rudzinska M, et al. Rotigotine effects on early morning motor function and sleep in Parkinson’s disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord. 2011;26(1):90–99. doi:10.1002/mds.23441
   PubMed Web of Science ®Google Scholar
• Di Giacopo R, Fasano A, Quaranta D, Della marca G, Bove F, Bentivoglio AR. Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson’s disease. Mov Disord. 2012;27(4):559–561. doi:10.1002/mds.24909
   PubMed Web of Science ®Google Scholar
• Brunetti V, Losurdo A, Testani E, et al. Rivastigmine for refractory REM behavior disorder in mild cognitive impairment. Curr Alzheimer Res. 2014;11(3):267–273. doi:10.2174/1567205011666140302195648
   PubMed Web of Science ®Google Scholar
• Ringman JM, Simmons JH. Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology. 2000;55(6):870–871. doi:10.1212/wnl.55.6.870
   PubMed Web of Science ®Google Scholar
• Larsson V, Aarsland D, Ballard C, Minthon L, Londos E. The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson’s disease dementia. Int J Geriatr Psychiatry. 2010;25(10):1030–1038. doi:10.1002/gps.2506
   PubMed Web of Science ®Google Scholar
• Chagas MHN, Eckeli AL, Zuardi AW, et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series. J Clin Pharm Ther. 2014;39(5):564–566. doi:10.1111/jcpt.12179
   PubMed Web of Science ®Google Scholar
• Anderson KN, Shneerson JM. Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J Clin Sleep Med. 2009;5(3):235–239.
   PubMed Web of Science ®Google Scholar
• Bamford CR. Carbamazepine in REM sleep behavior disorder. Sleep. 1993;16(1):33–34.
   PubMed Web of Science ®Google Scholar
• Abenza Abildúa MJ, Miralles Martinez A, Arpa Gutiérrez FJ, et al. Conditions associated with REM sleep behaviour disorder: description of a hospital series. Neurologia. 2019;34(3):159–164. doi:10.1016/j.nrl.2016.11.011
   PubMed Web of Science ®Google Scholar
• Keir LHM, Breen DP. New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson’s disease. J Neurol. 2020;267(1):288–294. doi:10.1007/s00415-019-09651-z
   PubMed Web of Science ®Google Scholar
• Meloni M, Figorilli M, Carta M, et al. Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson’s disease. Sleep Breath. 2022;26(3):1023–1031. doi:10.1007/s11325-021-02417-w
   PubMed Web of Science ®Google Scholar
• Shinno H, Kamei M, Nakamura Y, Inami Y, Horiguchi J. Successful treatment with Yi-Gan San for rapid eye movement sleep behavior disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(7):1749–1751. doi:10.1016/j.pnpbp.2008.06.015
   PubMed Web of Science ®Google Scholar
• Kunz D, Stotz S, Bes F. Treatment of isolated REM sleep behavior disorder using melatonin as a chronobiotic. J Pineal Res. 2021;71(2):e12759. doi:10.1111/jpi.12759
   PubMed Web of Science ®Google Scholar
• Cammisuli DM, Ceravolo R, Bonuccelli U. Non-pharmacological interventions for Parkinson’s disease mild cognitive impairment: future directions for research. Neural Regen Res. 2020;15(9):1650–1651. doi:10.4103/1673-5374.276329
   PubMed Web of Science ®Google Scholar
• Cristini J, Weiss M, De Las Heras B, et al. The effects of exercise on sleep quality in persons with Parkinson’s disease: a systematic review with meta-analysis. Sleep Med Rev. 2021;55:101384. doi:10.1016/j.smrv.2020.101384
   PubMed Web of Science ®Google Scholar
• McCarter SJ, Boeve BF, Graff-Radford NR, Silber MH, St Louis EK. Neuroprotection in idiopathic REM sleep behavior disorder: a role for exercise? Sleep. 2019;42(6):zsz064. doi:10.1093/sleep/zsz064
   PubMed Web of Science ®Google Scholar
• Hughes KC, Gao X, Molsberry S, Valeri L, Schwarzschild MA, Ascherio A. Physical activity and prodromal features of Parkinson disease. Neurology. 2019;93(23):e2157–e2169. doi:10.1212/WNL.0000000000008567
   PubMed Web of Science ®Google Scholar
• Frazzitta G, Maestri R, Ferrazzoli D, et al. Multidisciplinary intensive rehabilitation treatment improves sleep quality in Parkinson’s disease. J Clin Mov Disord. 2015;2:11. doi:10.1186/s40734-015-0020-9
   PubMedGoogle Scholar
• Memon AA, Coleman JJ, Amara AW. Effects of exercise on sleep in neurodegenerative disease. Neurobiol Dis. 2020;140:104859. doi:10.1016/j.nbd.2020.104859
   PubMed Web of Science ®Google Scholar
• Howell MJ, Arneson PA, Schenck CH. A novel therapy for REM sleep behavior disorder (RBD). J Clin Sleep Med. 2011;7(6):639–644A. doi:10.5664/jcsm.1470
   PubMed Web of Science ®Google Scholar
• Zuzuárregui JRP, During EH. Sleep Issues in Parkinson’s Disease and Their Management. Neurotherapeutics. 2020;17(4):1480–1494. doi:10.1007/s13311-020-00938-y
   PubMed Web of Science ®Google Scholar
• Pereira EA, Muthusamy KA, De Pennington N, Joint CA, Aziz TZ. Deep brain stimulation of the pedunculopontine nucleus in Parkinson’s disease. Preliminary experience at Oxford. Br J Neurosurg. 2008;22:S41–44. doi:10.1080/02688690802448335
   PubMedGoogle Scholar
• Stefani A, Lozano AM, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain. 2007;130(Pt 6):1596–1607. doi:10.1093/brain/awl346
   PubMed Web of Science ®Google Scholar
• Chambers NE, Lanza K, Bishop C. Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson’s Disease. Front Pharmacol. 2019;10:1494. doi:10.3389/fphar.2019.01494
   PubMed Web of Science ®Google Scholar